Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation

Perenlei Enkhbaatar, Kenji Okajima, Kazunori Murakami, Mitsuhiro Uchiba, Hiroaki Okabe, Kazutoshi Okabe, Yasuo Yamaguchi

Research output: Contribution to journal › Article › peer-review

76 Scopus citations

Fingerprint

Dive into the research topics of 'Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation'. Together they form a unique fingerprint.

Medicine & Life Sciences